gmp
gmp

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Neostigmine Methyl Sulfate

            Therapeutic Area: Musculoskeletal Product Name: Bloxiverz

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Exela Pharma Sciences, LLC.

            Deal Size: $42.0 million Upfront Cash: $14.5 million

            Deal Type: Divestment July 01, 2020

            Details:

            Company announced the sale of its portfolio of sterile injectable drugs used in the hospital setting, including three commercial products, Bloxiverz®, Vazculep®, and Akovaz®, as well as Nouress™ o Exela Sterile Medicines LLC.